US Patent 11254912 Methods and compositions for treating cancer
Patent 11254912 was granted and assigned to CRISPR Therapeutics on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11254912 Methods and compositions for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.